Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis by Quiliano, Miguel et al.
open access  www.bioinformation.net Hypothesis
  Volume 6(9)   
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 6(9): 335-339 (2011)  335             © 2011 Biomedical Informatics
 
Structure-Activity relationship in mutated 
pyrazinamidases from Mycobacterium tuberculosis 
 
 
Miguel Quiliano
1, Andres Hazaet Gutierrez
1, Robert Hugh Gilman
1, 2, César López
1, 
Wilfredo Evangelista
1, Jun Sotelo
1, Patricia Sheen
1, Mirko Zimic
1*  
 
 
1Unidad de Bioinformática y Biología Molecular, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano 
Heredia; 
2Department of International Health, Bloomberg School of Public Health, The Johns Hopkins University; Mirko Zimic - Email: mzimic@jhsph.edu; 
Phone: (511) 483-2942; Fax: (511) 483-2942; *Corresponding author 
 
 
Received June 22, 2011; Accepted June 28, 2011; Published July 19, 2011 
 
 
Abstract: 
The  pncA gene codes the pyrazinamidase of Mycobacterium tuberculosis, which converts pyrazinamide to ammonia and pyrazinoic-acid, the active anti-
tuberculous compound. Pyrazinamidase mutations are associated to pyrazinamide-resistant phenotype, however how mutations affect the structure of the 
pyrazinamidase, and how structural changes affect the enzymatic function and the level of pyrazinamide-resistance is unknown. The structures of mutated 
pyrazinamidases from twelve Mycobacterium tuberculosis strains and the pyrazinamide-susceptible H37Rv reference strain were modelled using homology 
modelling and single amino acid replacement. Physical-chemical and structural parameters of each pyrazinamidase were calculated. These parameters were:  The 
change of electrical charge of the mutated amino acid, the change of volume of the mutated amino acid, the change of a special amino acid, the distance of the 
mutated amino acid to the active site, the distance of the mutated amino acid to the metal-coordination site, and the orientation of the side-chain of the mutated 
amino acid. The variability of the enzymatic activity of the recombinant pyrazinamidases, and the microbiological susceptibility to pyrazinamide determined by 
BACTEC 460TB, were modelled in multiple linear regressions. Physical-chemical and structural parameters of the mutated pyrazinamidases were tested as 
predictors. Structural and physical-chemical variations of the pyrazinamidase explained 75% of the variability of the enzymatic activity, 87% of the variability of 
the kinetic constant and 40% of the variability of the pyrazinamide-resistance level. Based on computer models of mutated pyrazinamidases, the structural 
parameters explained a high variability of the enzymatic function, and to a lesser extent the resistance level.  
 
 
 
 
Background: 
According to WHO, tuberculosis disease due to Mycobacterium tuberculosis 
infection caused an estimated 1.3 million deaths, globally. Pyrazinamide (PZA) 
is an important first-line drug for tuberculosis (TB) and appears to be the most 
important drug killing M. tuberculosis in its latent stage [1-3]. The concomitant 
emergence of strains resistant to PZA represents an important public health 
problem as the efficacy of primary and standardized re-treatment regimens may 
be inadequate. PZA-susceptible strains possess a pyrazinamidase (PZAse) that 
converts PZA to ammonia and pyrazinoic acid (POA). POA is the active 
compound and is transported outside the Mycobacterium by an efflux pump. If 
the extracellular environment is acid, POA is protonated, returns to 
Mycobacterium by passive diffusion, and releases the proton. The acidification 
of the intracellular environment together with the accumulation of intracellular 
POA lethally alters the membrane permeability [4]. The major mechanism of 
PZA-resistance is considered to be the loss of PZAse activity linked to 
mutations in the pncA, the PZAse coding gene. Previous studies showed that 
mutations in recombinant PZAses decreased the enzymatic activity in about 10 
fold, according to the localization of the mutation and the type of substitution 
[5, 6]. In addition, mutations in PZAses have been shown to generate clinical 
resistance to PZA [7-9]. The causal pathway that links pncA mutations with 
PZA resistance should be:  [pncA mutations] Æ [PZAse structural change] Æ 
[PZAse functional change] Æ [PZA resistance level] Æ [“yes/no” PZA-
resistant phenotype]. In order to understand how pncA mutations affect the 
enzymatic function, it is necessary to analyse the three-dimensional structure of 
mutated PZAses. Previous studies determined structural models of M. 
tuberculosis PZAse for the PZA-resistant reference strain H37Rv.  
 
In these studies the PZAse structure was determined by homology modelling 
based on the crystallized structures of the homologues Arthrobacter N-
carbamoylsarcosine aminohydrolase (CHSase) [5] and Pyrococcus horikoshii 
PZAse [10, 11]. Theoretical structural models serve as good approaches when 
experimental structure data are not available [12]. In a recent study, the PZAse 
structure of the M. tuberculosis H37Rv strain was resolved by crystallography 
[13], showing that the structure of PZAses are highly conserved among these 
species. The critical residues associated with PZAse function are those of the 
active site (D8, A134, C138) and the metal-binding site (D49, H51, H57, and 
H71). Mutations in these residues and in residues in close proximity to these 
sites highly affect the PZAse function [6, 11]. In the present work, we studied 
the relationship between structural and physical-chemical characteristics of 
mutated PZAses with the enzymatic function and PZA-resistance level of M. 
tuberculosis strains.  
 
Methodology: 
PZAse selection: 
In a previous work, the PZAse of the H37Rv strain and 12 mutated PZAses 
(D12G, D12A, G24D, Y34D, K48T, D49N, H51R, T76P, G78C, F94L, L116P, 
and T135P), from M. tuberculosis PZA-resistant strains were cloned, 
expressed, and purified. The catalytic constant kcat, and the enzymatic activity BIOINFORMATION  open access 
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were measured for each recombinant enzyme. The PZA-MIC and the growth-
index in BACTEC-460TB at 100 µg/mL PZA were measured for each strain 
[6]. Data of PZAse function and PZA-resistance is shown in the Table 4 (see 
supplementary material).  
 
Modelling: 
Theoretical structures were obtained by homology modelling and single amino 
acid replacement. For each PZAse, two theoretical structures were generated. 
The first set of structures was obtained by single amino acid replacement using 
as template the crystal structure of the M. tuberculosis H37Rv PZAse (PDB 
3pl1). The second set was obtained by homology modelling using as template 
the  P. horikoshii PZAse crystal structure (PDB 1im5). Modelled structures 
were refined by energy minimization and molecular dynamics. Energy 
minimization was performed with GROMACS [14], using the steepest-descent 
algorithm with a convergence gradient of 10 KJ×mol
-1×nm
-1. Structures were 
solvated in explicit water followed by 1ns molecular dynamics (MD) using 
GROMACS. The accuracy of the models were evaluated using PROCHECK 
[15].  
 
Physical-chemical and structural parameters:  
Parameters estimated for the mutated aminoacid included: (1) change of 
electrical charge; (2) change of volume; (3) change of a special aminoacid; (4) 
closeness to the active site; (5) closeness to the metal coordination site (MCS); 
and (6) orientation of the side chain (Tables 1 & 2, see Supplementary 
material). Aminoacids were considered as: hydrophilic (Basic: K, R and H; 
Acidic: D and E; and polar with uncharged side-chain group: S, T, N and Q), 
hydrophobic (A, V, I, L, M, F, Y and W) and special (C, G and P). The volume 
change was calculated using Pontius values [16]. The closeness of the mutated 
aminoacid to the active-site and to the MCS, was measured as the distance 
between the alpha-carbon of the mutated aminoacid and the alpha-carbons of 
the 3 residues of the active-site (D8, A134, C138) and 3 residues of the MCS 
(D49, H51, H71). In order to prevent a bias due to over-modelling, amino acid 
H57 was not considered because its orientation and position in an external 
loop, showed a low structural stability during the MD run. The distance 
between the barycentre of the 3 alpha-carbons of the active-site residues and 
the alpha-carbon of the mutated aminoacid (D_AS) was determined. Similarly, 
the equivalent distance to the MCS (D_MCS) was also determined.  
 
The orientation of the side-chain of the mutated aminoacid was determined by 
the distance between the barycentre of the 3 alpha-carbons of the active-site 
residues and the intersection of the projection of the mutated side-chain with 
the plane defined by the alpha-carbons of the active-site (d_AS). The projection 
of the side-chain was defined as the resultant vector connecting the alpha-
carbon with each of the atoms of the side-chain. Similarly, we calculated the 
equivalent distance for the MCS (d_MCS). We calculated the angle between 
the projection of the mutated side-chain and the normal vector of the plane 
defined by the alpha-carbons of the active site (α_AS). We calculated the 
equivalent angle to the plane defined by the alpha-carbons of the MCS 
(α_MCS). The orientation of the side-chain of the mutated aminoacid was 
classified accordingly to whether its projection crosses the triangle formed by 
the 3 alpha-carbons of the active-site (AS_triangle), and to whether its 
projection aims at the plane defined by the alpha-carbons of the active-site 
(AS_plane). We classified the orientation of the side-chain of the mutated 
amino acid against the MCS triangle (MCS_triangle), and the MCS plane 
(MCS_plane).  
 
Prediction of PZAse-function and PZA-susceptibility:  
The variability of the growing-index in BACTEC, the enzymatic activity and 
kcat were modelled in a linear regression. The structural and physical-chemical 
parameters were tested as predictors. The PZA-MIC was also tested as a 
dichotomous variable: Low-MIC (MIC< 400µg PZA/mL) versus high-MIC 
(MIC>=400µg PZA/mL). The variability of PZA-MIC was modelled in a 
logistic regression.  
 
Discussion: 
This study presents the relationship of theoretical structure models of M. 
tuberculosis mutated PZAses with a single amino acid substitution with PZAse 
enzymatic-function and strain PZA-susceptibility. The structural alignment 
between P. horikoshii and H37Rv M. tuberculosis crystallized PZAses, shows 
that both structures are highly conserved (RMSD=0.661 A at backbone level). 
The MCS for H37Rv M. tuberculosis PZAse is proposed to be composed by 
residues D49, H51, H57, and H71 [13] in contrast to the corresponding of P. 
horikoshii that lacks H57 [6, 11]. H57 in M. tuberculosis PZAse is located in a 
loop, which shows structural instability as detected by the MD simulation. To 
prevent any bias during MD simulation, we obviate the H57 for the extraction 
of structural parameters. After excluding the H57-loop-region, the two 
predicted structures of each mutated PZAse were highly similar (RMSD = 0.5 
A at backbone level). All results described below were similar for the two 
models. The major structural changes of the mutated PZAses were in the 
orientation of the amino acid side-chains and in a lesser extent the backbone. 
The structural and physical-chemical parameters were able to explain a high 
variability of the PZAse function and in a lesser extent the variability of the 
PZA-resistance level.  
 
The physical-chemical and structural parameters for the 12 mutated PZAses are 
shown in Tables 1 & 2 (see supplementary material). In the univariate 
analysis, the enzymatic activity, the kcat, and the Bactec growing index were 
significantly associated with several structural parameters (Table 3, see 
Supplementary material). After adjustment, the best multiple linear model to 
explain the enzymatic activity included the distance d_MCS (P=0.005) with a 
determination coefficient R
2 of 0.76.  The best multiple linear model for the 
catalytic constant kcat included the change of electrical charge (P=0.001), the 
distance d_A134 (P=0.003), the angle α_MCS (P=0.05), and the indicator 
variable AS_plane (P=0.024), with a determination coefficient R
2 of 0.88. The 
variability of the growing index in BACTEC was significantly associated with 
the angle α_MCS (P=0.027) with a determination coefficient R
2 of 0.40. The 
change of electrical charge was the dominant term in the models. Therefore, the 
most important structural parameters able to explain the variability of the 
PZAse activity and kcat were related to the physical-chemistry properties of the 
active site and the MCS. The closeness of the mutation to A134 as a predictor 
confirms the importance of the active site in the hydrolysis of PZA. As 
described by Du et al. (2001) the initial interaction of PZA with the PZAse 
active site at the beginning of the hydrolysis occurs very close to A134 [11]. 
The closeness of the mutation and the orientation of the mutated amino acid 
side chain towards the MCS, confirm the importance of the MCS in the 
hydrolysis of PZA, and explain the high MIC observed in mutations that are 
close to the MCS and their side chains aim directly at it. Lemaitre et al. in 2001 
have previously discussed that the level of activity displayed by PZAse mutants 
is correlated with the location of the substituted amino acids [5]. Those that are 
close to the catalytic site diminish the activity of the enzyme more than those 
that are far apart [5]. We found that this is not generally true. This study 
showed that the PZAse structure is a proximal predictor of PZAse function, 
confirming the well-known structure-function relationship. The lack of a high 
association between the PZAse structure and PZA-resistance level suggests that 
an important amount of PZA-resistance is determined by other factors than 
PZAse structure/function.  
 
Conclusion:  
Our results showed that the PZAse structure was able to explain a high 
variability of the enzymatic function, but in a lesser extent the PZA-resistance 
level in M. tuberculosis. The PZAse structural aspects that best explained the 
variability of the enzymatic activity were those associated to the physical-
chemical characteristics of the AS and the MCS. Despite the small number of 
mutations analyzed, our results confirm that the PZAse structure is a proximal 
predictor of PZAse function, confirming the well-known structure-function 
relationship. The lack of an important association between the PZAse structure 
and the PZA-resistance level suggests that an important amount of PZA-
resistance is determined by other factors than PZAse activity.  
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Supplementary material: 
 
Table 1: Variation of the physical-chemical characteristics of the mutated amino acid  
Mutation  Change of electrical charge  Change of volume (A
3)  Change of a special amino acid 
D12A  Polar charged (acid)-Non polar  43.7  - 
D12G  Polar charged (acid)-Non polar  67.7  Gain of Special G 
G24D  Non polar-Polar charged (acid)  -67.7  Loss of Special G 
Y34D  Non polar-Polar charged (acid)  74.6  - 
K48T Polar  charged-Polar  uncharged  36.5  - 
D49N Polar  charged-Polar  uncharged  -3.1  - 
H51R No  -32.9  - 
T76P  Polar uncharged-Non polar  2.6  Gain of Special P 
G78C  Non polar-Polar uncharged   -48.4  Gain of -SH (C) 
F94L No  22.69  - 
L116P  No  40  Gain of Special P 
T135P  Polar uncharged-Non polar  2.6  Gain of Special P 
Change of electric charge, change of special amino acid and change of volume (A
3) for all mutations studied. 
 
Table 2: Structural parameters of the mutated pyrazinamidases 
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D12A  9.48  13.74 16.09 2.67 5.124 12.38 No  No  10.02  11.17  5.1  1.053  9.21  8.07  No  No 
D12G  8.53  12.21 14.71 2.5  3.111 12.37 No  No  9.58  11.25  4.62  0.876  7.67  8.03  No  No 
G24D  11.2  10.51 15.92 2.06 9.643 10.57 No  No  16.66  20.71  14.11  0.922  13.38  14.75  Yes  No 
Y34D  18.27 20.8  24.39 1.05 10.09 20.68 No  Yes  24.38  30.12  26.14  1.005  15.52  26.64  No  No 
K48T  5.25  14.07 15.49 2.05 7.56  10.34 No  No  3.84  9.51  10.6  0.209  7.16  7.35  No  No 
D49N 0  6.31 8.09 2.6 6.566  9.471  No  No  6.4  13.12 11.58 1.462 4.06  4.06  Yes Yes 
H51R 6.29 0  7.88 2.67  7.045  14.14  No  No  12.25  17.16 15.28 1.623 3.91  3.91  Yes No 
T76P  15.38 20.65 21.65 2.66 4.984 18.74 No  Yes  12.73  10.19  8.87  1.016  7.75  9.81  Yes  Yes 
G78C  10.53 17.24 18.56 2.55 6.496 15  No  Yes  9.4  9.91  7.67  0.899  9.95  7.94  Yes  Yes 
F94L  10.15 16.34 13.24 2.11 6.378 12.48 No  Yes  4.55  6.96  11.97  1.544  45.57  7.22  No  No 
L116P 13.01 18.76 16.03 1.06 4.376 15.28 No  Yes  13.54  18.83  21.1  1.526  46.56  17.58  No  No 
1Distance (Angstrom) between the alpha carbon of the mutated amino acid and the alpha carbons of the residues of the AS/MCS; 
2 Angle between the projection of 
the mutated side chain and the normal vector of the plane defined by the alpha carbons of the AS/MCS; 
3 Distance (A) between the barycenter of the 3 alpha 
carbons of the AS/MCS residues and the intersection of the projection of the mutated side chain with the plane defined by the alpha carbons of the AS/MCS; 
4 
Distance (A) between the barycenter of the 3 alpha carbons of the AS/MCS, and the alpha carbon of the mutated amino acid; 
5 Classification of the side chain 
mutated amino acid orientation accordingly to whether its projection crosses the triangle formed by the 3 alpha carbons of the AS/MCS; 
6 and to whether its 
projection aims at the plane defined by the alpha carbons of the AS/MCS. 
 
Table 3: Single and multivariable regression models for the prediction of the PZA susceptibility and the PZAse kinetic parameters. 
   Logistic  regression  Linear  regression 
   MIC  Activity  KM k cat  Growth %    
Covariate SVM  BMM  SVM  BMM  SVM  BMM  SVM  BMM  SVM  BMM 
Charge change  -0.916  -  -15.497  -  -0.698  -  -495.63  -726.711  -1.889  - 
  (0.512)  -  (0.097)  -  (0.203)  -  (0.044) (0.001) (0.914)  - 
Volume change  0.006  -  0.158  -  -0.001  -  4.038  -  0.008  - 
  (0.672)  -  (0.094)  -  (0.854)  -  (0.120)  -  (0.966)  - 
Special  change  -1.386 -  3.815 -  -0.653  -  85.612 -  -1.833  - 
  (0.258)  -  (0.659)  -  (0.166)  -  (0.716)  -  (0.903)  - 
d_D8  -0.293 -  1.185 -  -0.092  -  25.953 -  1.030  - 
(0.149)  -  (0.190)  -  (0.062)  -  (0.300)  -  (0.527)  - 
d_A134  -0.348 -  1.300 -  -0.035  -  31.580 90.919 -1.442  - 
(0.088)  -  (0.032)  - (0.357)  -  (0.060)  (0.003)  (0.205)  - 
d_C138  -1.859 -  0.993 -  -0.072  -  19.360 -  -1.285  - 
(0.272)  -  (0.206)  -  (0.099)  -  (0.376)  -  (0.357)  - 
α_AS   1.732  -  -15.716  -  0.091  -  -384.285  -  4.831  - BIOINFORMATION  open access 
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(0.191)  -  (0.017)  -  (0.834)  -  (0.039)  -  (0.714)  - 
d_AS   0.052  -  -1.097  -  -0.018  -  -30.711  -  1.855  - 
(0.700)  -  (0.247)  -  (0.743)  -  (0.232)  -  (0.261)  - 
D_AS    -0.376 -  1.461 -  -0.046  -  29.867 -  -0.038  - 
(0.130)  -  (0.183)  -  (0.477)  -  (0.327)  -  (0.985)  - 
AS_triangle -  -  -  -  -  -  -  -  -  - 
- -  -  -  -  -  - - -  - 
AS_plane -2.303  - -16.140  - 0.035  -  409.573  -681.649  -9.000  - 
(0.099)  -  (0.042)  -  (0.944)  -  (0.062)  (0.024)  (0.553)  - 
d_D49 -0.140  -  0.292  -  -0.049  -  0.034  -  1.795  - 
(0.276)  -  (0.712)  -  (0.264)  -  (0.999)  -  (0.172)  - 
d_H51 -0.090  -  0.312  -  -0.015  -  2.089  -  1.164  - 
(0.382)  -  (0.648)  -  (0.700)  -  (0.911)  -  (0.317)  - 
d_H71  -0.148 -  1.025 -  0.016 -  23.170 -  0.360  - 
(0.236)  -  (0.135)  -  (0.692)  -  (0.223)  -  (0.775)  - 
α_MCS   3.386  -  -1.279  -  0.600  -  9.843  303.592  27.128  27.128 
(0.124)  -  (0.873)  -  (0.166)  -  (0.964)  (0.050) (0.027)  (0.027) 
d_MCS  -0.014 -  0.768 0.635  0.014 -  22.609 -  -0.258  - 
(0.736)  -  (0.001) -0.005 (0.416)  -  (0.000)  -  (0.626)  - 
D_MCS  -0.207 -  0.921 -  -0.038  -  18.836 -  0.448  - 
(0.154)  -  (0.154)  -  (0.310)  -  (0.109)  -  (0.704)  - 
MCS_triangle -0.693 -  -13.891  -  0.217 -  -386.537  -  4.029  - 
(0.560)  -  (0.089)  -  (0.664)  -  (0.081)  -  (0.792)  - 
MCS_plane -0.916  -  9.103  -  0.476  -  272.334  -  -5.222 - 
(0.512)  -  (0.353)  -  (0.397)  -  (0.305)  -  (0.764)  - 
Structural parameters and physical-chemical characteristics against kinetic parameters of recombinant pyrazinamidases used to generate Single Variable Models 
(SVM) and Best Multiple Models (BMM). P-values, in parenthesis, and coefficients are reported. Significant values are in bold.  
 
Table 4: Pyrazinamide susceptibility of Mycobacterium tuberculosis isolates and kinetic parameters of their corresponding recombinant pyrazinamidase. 
pncA 
mutation 
  PZA  BACTEC 
460TB
2 
Activitiy
3  kcat
4 
  MIC
1 
T135P >800  98  0.02 0.45 
H51R >800  90  0.006  0.17 
D49N 400  74  0.045  1.53 
T76P 200  89  8.99  202.98 
L116P 100 46  50.15  1324.5 
D12A 400  77  9.24 245.17 
D12G 400  70  14  368.46 
F94L 400  70  21.19  712.92 
G24D 200  68  4.28 100.13 
Y34D 100  78  20.58  386.4 
G78C 100  27  6.96 105.16 
K48T  ≤50 20  10.45  241.82 
Wild type  ≤50 1  38.4  1005.41 
1PZA MIC (μg PZA/ml); 
2BACTEC 460TB, PZA Growth index; 
3Activity, μmol POAmin
-1mg
-1 PZAse;
 4kcat, min
-1.  
 
 
 
 
 
 
 